基本信息
浏览量:605
职业迁徙
个人简介
AREAS OF SPECIAL INTEREST
Special interest in genitourinary malignancies (prostate, kidney, bladder and testicular cancer), thoracic and lung cancer as well as clinical research, particularly phase 1 trials for all solid tumors.
EXPERIENCE
Dr. Vogelzang is a renowned medical oncologist and cancer researcher at Comprehensive Cancer Centers. He is the chairman of medical oncology at Comprehensive. He is also vice chair of GU Committee SWOG, a worldwide network of researchers that design and conduct cancer clinical trials. Dr. Vogelzang serves as Clinical Professor of Medicine at University of Nevada, Reno School of Medicine and UNLV School of Medicine.
Dr. Vogelzang leads and participates in multiple clinical trials in genitourinary malignancies, phase 1 and mesothelioma focusing on new therapies for patients with metastatic kidney, bladder and prostate cancer. In 2019, Dr. Vogelzang enrolled the first patient in the world on a phase 1 clinical trial drug known as ARV-110 for advanced stage prostate cancer patients. Dr. Vogelzang also led efforts in bringing a promising new therapy for those with advanced stage prostate cancer known as 177Lu-PSMA-617 to Las Vegas.
In December 2018, one of Dr. Vogelzang’s patients became the very first in Nevada to receive the treatment. And in 2014, Nature published the international phase 1 team’s research on an anti-PD-L1 treatment called atezolizumab (commercially known as TECENTRIQ) for metastatic bladder cancer. The FDA approved the treatment in May 2016 and Dr. Vogelzang’s patient was the first in the world to receive the commercial treatment.
As a result of Dr. Vogelzang’s efforts in research, he has helped lead several studies to FDA-approval including PROVENGE and Xofigo®, among others.
Prior to joining Comprehensive, he served as Director of Nevada Cancer Institute from 2004 to 2009. From 1999 to 2003, Dr. Vogelzang was Fred C. Buffett Professor and Director of the University of Chicago Medicine Comprehensive Cancer Center and faculty member from 1982 to 2003.
Dr. Vogelzang has authored/coauthored numerous peer-reviewed articles, book chapters and abstracts. He was the lead editor of the Comprehensive Textbook of Genitourinary Oncology from 1994 to 2008.
Dr. Vogelzang was named Distinguished Physician of the Year by the Nevada State Medical Association and received the Giants of Cancer Care® award from OncLive®, Gold Certificate of Excellence award from National Cancer Institute, Everyday Hero award from the American Red Cross Southern Nevada, Laureate award from the American College of Physicians in Nevada and the Inspired Excellence in Health Care Award from Las Vegas HEALS. He has been named America’s Top Doctor by Castle Connolly and Top Doctor by U.S. News & World Report, Newsweek magazine, Chicago magazine, VEGAS INC Health Care Quarterly, Vegas Seven, Las Vegas Life and Desert Companion. He was awarded Health Care Headliner by VEGAS INC and Medical Marvel from Nevada Business Magazine. He has been recognized among America’s Most Honored Professionals by The American Registry and consistently receives the Compassionate Doctor, Patients’ Choice, On-Time Physician and Top 10 Oncologists awards from Vitals.com.
Dr. Vogelzang has been featured in several national and local media outlets in relation to his cancer research work including The New York Times, USA Today, New England Journal of Medicine, Nature, 60 Minutes and the Las Vegas Review-Journal.
Dr. Vogelzang has served on numerous committees for the American Society of Clinical Oncology, as well as on its board of directors for three years.
BOARD CERTIFIED
Internal Medicine
Medical Oncology
MEMBERSHIPS IN PROFESSIONAL ASSOCIATIONS
American Association of Cancer Research
American College of Physicians – Fellow
American Society of Clinical Oncology – Fellow
American Urological Association
Clark County Medical Society
European Society for Medical Oncology
International Association for the Study of Lung Cancer
Kidney Cancer Association
Mesothelioma Foundation
Nevada Oncology Society
Society of Urologic Oncology
Special interest in genitourinary malignancies (prostate, kidney, bladder and testicular cancer), thoracic and lung cancer as well as clinical research, particularly phase 1 trials for all solid tumors.
EXPERIENCE
Dr. Vogelzang is a renowned medical oncologist and cancer researcher at Comprehensive Cancer Centers. He is the chairman of medical oncology at Comprehensive. He is also vice chair of GU Committee SWOG, a worldwide network of researchers that design and conduct cancer clinical trials. Dr. Vogelzang serves as Clinical Professor of Medicine at University of Nevada, Reno School of Medicine and UNLV School of Medicine.
Dr. Vogelzang leads and participates in multiple clinical trials in genitourinary malignancies, phase 1 and mesothelioma focusing on new therapies for patients with metastatic kidney, bladder and prostate cancer. In 2019, Dr. Vogelzang enrolled the first patient in the world on a phase 1 clinical trial drug known as ARV-110 for advanced stage prostate cancer patients. Dr. Vogelzang also led efforts in bringing a promising new therapy for those with advanced stage prostate cancer known as 177Lu-PSMA-617 to Las Vegas.
In December 2018, one of Dr. Vogelzang’s patients became the very first in Nevada to receive the treatment. And in 2014, Nature published the international phase 1 team’s research on an anti-PD-L1 treatment called atezolizumab (commercially known as TECENTRIQ) for metastatic bladder cancer. The FDA approved the treatment in May 2016 and Dr. Vogelzang’s patient was the first in the world to receive the commercial treatment.
As a result of Dr. Vogelzang’s efforts in research, he has helped lead several studies to FDA-approval including PROVENGE and Xofigo®, among others.
Prior to joining Comprehensive, he served as Director of Nevada Cancer Institute from 2004 to 2009. From 1999 to 2003, Dr. Vogelzang was Fred C. Buffett Professor and Director of the University of Chicago Medicine Comprehensive Cancer Center and faculty member from 1982 to 2003.
Dr. Vogelzang has authored/coauthored numerous peer-reviewed articles, book chapters and abstracts. He was the lead editor of the Comprehensive Textbook of Genitourinary Oncology from 1994 to 2008.
Dr. Vogelzang was named Distinguished Physician of the Year by the Nevada State Medical Association and received the Giants of Cancer Care® award from OncLive®, Gold Certificate of Excellence award from National Cancer Institute, Everyday Hero award from the American Red Cross Southern Nevada, Laureate award from the American College of Physicians in Nevada and the Inspired Excellence in Health Care Award from Las Vegas HEALS. He has been named America’s Top Doctor by Castle Connolly and Top Doctor by U.S. News & World Report, Newsweek magazine, Chicago magazine, VEGAS INC Health Care Quarterly, Vegas Seven, Las Vegas Life and Desert Companion. He was awarded Health Care Headliner by VEGAS INC and Medical Marvel from Nevada Business Magazine. He has been recognized among America’s Most Honored Professionals by The American Registry and consistently receives the Compassionate Doctor, Patients’ Choice, On-Time Physician and Top 10 Oncologists awards from Vitals.com.
Dr. Vogelzang has been featured in several national and local media outlets in relation to his cancer research work including The New York Times, USA Today, New England Journal of Medicine, Nature, 60 Minutes and the Las Vegas Review-Journal.
Dr. Vogelzang has served on numerous committees for the American Society of Clinical Oncology, as well as on its board of directors for three years.
BOARD CERTIFIED
Internal Medicine
Medical Oncology
MEMBERSHIPS IN PROFESSIONAL ASSOCIATIONS
American Association of Cancer Research
American College of Physicians – Fellow
American Society of Clinical Oncology – Fellow
American Urological Association
Clark County Medical Society
European Society for Medical Oncology
International Association for the Study of Lung Cancer
Kidney Cancer Association
Mesothelioma Foundation
Nevada Oncology Society
Society of Urologic Oncology
研究兴趣
论文共 674 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn